Murine parvoviruses, including minute virus of mice (MVM), represent major infectious disease problems encountered in contemporary laboratory animal research facilities with embryo transfer (ET), one of the most widely used techniques for rederivation. Using an in vivo approach, the objectives of this study were to assess the risk of MVM transmission during rederivation and to provide data that allow recommendation of preventive measures. Therefore, we determined whether immunosuppressive variant MVMi viral DNA is detectable in reproductive organs, gametes (oocytes and spermatozoa), and embryos collected from experimentally infected mice and whether washing as recommended before ET eliminates MVMi sufficiently from gametes and embryos. Fractions of reproductive organs tested positive from Day 5 to Day 30 postinoculation, demonstrating a risk for a minimum period of 4 wk; the highest incidence of positive organs was found between Day 9 and Day 13 postinoculation. Real-time PCR detected viral DNA to a lesser extent in male than in female reproductive organs. MVMi DNA was detected in oocytes and sperm cells derived after in vivo infection but not in two-cell embryos. In vitro contamination studies revealed that the virus firmly adheres to the zona pellucida after 10 wash steps, indicating that even extensive washing might not eliminate MVMi completely from embryos. According to this systematic in vivo approach, recommended measures to prevent transmission of MVM during rederivation include sufficient washing of embryos, accompanying testing using adequate (PCR) methods, and using embryos rather than in vitro fertilization techniques; furthermore, the exchange of gametes should be considered a risk factor.
INTRODUCTION
Murine parvoviruses, including minute virus of mice (MVM), represent one of the most significant infectious disease problems encountered in contemporary laboratory animal research facilities, despite strict barrier systems and extensive health monitoring programs [1] [2] [3] . The prototype strain MVMp was originally isolated by Crawford [4] in 1966, while the immunosuppressive variant MVMi was isolated from a transplantable mouse lymphoma [5] . Although clinical signs and morbidity have been observed after experimental infection, natural infection in mice is usually asymptomatic [6, 7] . However, MVM can have a detrimental effect on biomedical research because of its immunomodulatory effects [4, [8] [9] [10] [11] [12] . Furthermore, the high degree of environmental stability enhances the problem of elimination of MVM from infected mouse colonies [13, 14] .
One of the most widely used techniques for rederivation of infected mouse colonies is embryo transfer (ET), generally implanting two-cell embryos into specified pathogen-free dams. Embryos are either derived directly from the infected female or gained by in vitro fertilization (IVF) technique using spermatozoa and oocytes from infected mice. To prevent transmission of infectious pathogens, the International Embryo Transfer Society recommends washing embryos 10 times before ET [15] .
Oocytes and preimplantation embryos are surrounded by the zona pellucida (zp), a protecting glycoprotein membrane. An intact zp acts as a natural barrier against viruses, preventing transmission of infectious agents during ET [16] [17] [18] . Nevertheless, very small viruses such as picornaviruses (e.g., Mengo virus and Coxsackie B-4) and even porcine parvovirus have been shown to traverse the zp of murine embryos [19] [20] [21] . Furthermore, microspheres similar in size to parvoviruses were able to cross the zp [22] . Consequently, MVM might penetrate this protective barrier, which has been addressed experimentally using direct fluorescent antibody technique only. Moreover, micropores in the zp may allow entrapment of small viruses like MVM even after extensive washing of embryos [23] . Therefore, it remains to be determined whether common decontamination techniques such as washing are sufficient to prevent MVM transmission during the ET process when oocytes, two-cell embryos, and spermatozoa are derived after an in vivo infection.
A potential risk of parvovirus transmission during rederivation was indicated by an investigation using mouse parvovirus (MPV)-inoculated immunodeficient mice, by an observation in an endemically MPV-infected colony, and by an experimental in vitro approach using MVMp [22, [24] [25] [26] . A systematic experimental in vivo approach to determine the risk of MVM transmission during rederivation in immunocompetent mice is lacking so far. Because ET is one of the primary mechanisms to eradicate MVM from endemically infected colonies, the objectives of this study were to assess the risk of MVM transmission during rederivation using an in vivo approach, thereby providing data that allow recommendation of preventive measures. This was achieved by investigating whether, when, and to what extent MVMi viral DNA can be detected in reproductive organs, gametes (oocytes and spermatozoa), and embryos collected from experimentally infected mice. This in vivo-in vitro approach has not been addressed previously, to our knowledge. Furthermore, we investigated to what extent washing as recommended before ET eliminates MVMi sufficiently from gametes and embryos.
MATERIALS AND METHODS

Mice
Specified pathogen-free FVB/N mice (Ztm), aged 10-12 wk, were obtained from the Central Animal Facility of Hannover Medical School. Routine microbiological monitoring according to Federation of European Laboratory Animal Science Associations recommendations did not reveal any evidence of infection with common murine pathogens [27] . For infection experiments, mice were maintained under negative pressure in plastic film isolators (Metall þ Plastic GmbH, Radolfzell-Stahringen, Germany) or in microisolation caging (located in a room with a controlled environment of 21 6 28C, 55% 6 5% relative humidity, 12L:12D cycle, and 12-14 air changes hourly). Pelleted irradiated diet (ssniff M-Z; Spezialdiäten, Soest, Germany) containing 22.0% protein, 4.5% fat, and 3.9% fiber and autoclaved distilled water were provided ad libitum.
This study was conducted in accord with German law for animal protection and with the European Communities Council Directive 86/609/EEC for the protection of animals used for experimental purposes. All experiments were approved by the local institutional animal care and research advisory committee and were permitted by the local government.
Virus
MVMi was propagated in NBK newborn kidney cells (both virus and cells were kindly provided by W. Nicklas, German Cancer Research Center, Heidelberg, Germany). NBK cells were maintained in 75-cm 2 culture flasks in M199 medium supplemented with 2% heat-inactivated fetal calf serum (FCS). Subconfluent cell cultures were infected with MVMi for 2-3 h, after which virus suspension was removed and replaced with M199. At complete cytopathic effect, cells underwent three freeze-thaw cycles. Contents of cell culture flasks were centrifuged at 5000 3 g for 5 min to pellet cell debris. Resulting viral stocks were stored at À808C until use. Titration of virus was performed as described previously [28] . Briefly, NBK cells were seeded in flatbottomed 96-well plates (7.5 3 10 3 cells/well) and cultured overnight in M199 medium supplemented with 10% FCS. After removal of culture medium, cells were infected with 300 ll of 10-fold dilutions of virus using 10 wells for each dilution. Cytopathic effect was determined on the sixth day of culture and was defined as complete loss of cell-cell contact (cell detachment). The mean tissue culture infective dose (TCID 50 ) was calculated according to the SpearmanKaerber method [29, 30] .
Infection Experiments
Mice were inoculated oronasally (each mouse received 3.5 3 10 2 TCID 50 ) by placing 10 ll on the external nares and applying 50 ll orally. Mice were maintained with husbandry conditions as already described and were euthanized by CO 2 inhalation and cardiocentesis. All organs harvested during necropsies were stored at À208C until use. Spleens of all animals were harvested to undergo MVMi-specific PCR to confirm that donors were infected. All manipulations on animals were performed in a class II biological safety cabinet under sterile conditions.
Collection of Reproductive Organs
To determine the presence of MVMi viral DNA in the reproductive tract after an in vivo infection, three mice of each gender were euthanized every second day from Day 1 postinoculation until Day 15 postinoculation and then every fifth day until Day 30 postinoculation. Harvesting of reproductive organs included ovary, oviduct, uterus, testis, epididymis, accessory glands (seminal vesicles and coagulation gland), and penis. Viral DNA derived from organs harvested on Day 9 postinoculation was analyzed using real-time PCR.
Oocyte and Two-Cell Embryo Collection
For harvesting of oocytes, mice were superovulated according to the Whittingham protocol by i.p. injection of 7 international units (IE) of equine chorionic gonadotropin (Intergonan; Intervet, Unterschleißheim, Germany) and 5 IE of human chorionic gonadotropin (HcG) (Sigma-Aldrich Chemie GmbH, Munich, Germany) 48 h later [31] . Oocytes were harvested approximately 14 h after HcG injection. Therefore, mice were euthanized, and oviducts containing cumulus-oocyte complexes were removed into M2 medium [32] . The ampulla of the oviduct was ruptured gently to free cell complexes into fresh medium. Cumulus cells were removed from oocytes by treatment with hyaluronidase (300 U/ml; Roth GmbH, Karlsruhe, Germany). Oocytes were collected in 150 ll of medium using a pulled glass pipette (inner diameter, 100-120 lm) and were transferred into dishes containing fresh medium for 5 or 10 wash steps. Washing of oocytes was carried out in 2 ml of medium. New glass pipettes were used for each wash step. Oocytes were pooled into groups consisting of 100 oocytes each; by pooling, we obtained the highest quality of DNA without decreasing sensitivity (three different DNA extraction kits were tested [data not shown]). Finally, oocytes were transferred into microfuge tubes for subsequent DNA extraction and PCR testing.
For collection of two-cell embryos, females were placed with male mice directly after i.p. injection of HcG and were checked for vaginal plugs the following morning. Embryos were harvested from mice 1.5 days after HcG injection. Uterus and oviduct were removed and placed in M2 medium. Embryos were then flushed from the oviduct into fresh medium using a Hamilton capillary and were submitted to 10-fold washing as already described.
Sperm Cell Collection
The cauda epididymides of mature male mice were bilaterally excised, placed on a sterile filter paper to remove adherent blood and fat tissue, and then cut and placed into microfuge tubes containing 500 ll of NaCl. Samples were allowed to incubate for 15 min at room temperature to release spermatozoa. Medium containing sperm cells was then placed into a fresh microfuge tube, leaving behind epididymal tissue. Sperm cells of each individual were treated separately and submitted to one, three, or five wash steps (resuspending cells in 400 ll of NaCl) with intermittent centrifugation at 500 3 g, followed by subsequent DNA extraction and PCR testing.
In Vitro Contamination of Oocytes
To determine whether MVMi adheres to the zp, oocytes were collected from uninfected superovulated FVB/N mice, treated with hyaluronidase, and washed carefully to remove cumulus cells. After washing, oocytes (groups consisted of 100 oocytes each) were placed into 140 ll of M16 medium containing 100 TCID 50 MVMi for a 2-h incubation period at 37C8 under oil cover. After incubation, oocytes were submitted to 10-fold washing as already described. Half of the oocytes of each group were either directly submitted to DNA extraction or submitted to treatment with acidic Tyrode solution to remove the zp. After dissolution of the zp, oocytes were washed and submitted to DNA extraction. Washing media and Tyrode solution (containing the dissolved zp) were submitted to PCR.
PCR Analysis
For PCR assays, total DNA was extracted from sperm cells using the Puregene DNA Purification Kit (Gentra Systems; Qiagen GmbH, Hilden, Germany) according to the manufacturer's instructions for extraction of DNA from 3 to 5 million sperm cells. DNA was extracted from oocytes and two-cell embryos using the NucleoSpin Tissue XS Kit (Macherey-Nagel, Düren, Germany) according to the manufacturer's instructions for extraction of DNA from 10 to 10 000 cells. DNA was extracted from mouse spleens using the NucleoSpin Tissue Kit in accord with the manufacturer's instructions. Washing media were submitted directly to PCR. Furthermore, total DNA was extracted from each wash step using the NucleoSpin Tissue Kit according to the manufacturer's instruction for supernatants.
DNA concentration and quality were determined using a NanoDrop spectrophotometer (ND-1000; PEQLAB Biotechnologie GmbH, Erlangen, Germany). Viral DNA was amplified using a generic parvovirus PCR assay specific for a 310-base pair (bp) product from the conserved NS gene region [33] . Primer sequences were MVM-1458 forward (5 0 -ACC-AGC-CAG-CAC-AGG-CAA-ATC-TAT-3 0 ) and MVM-1791 reverse (5 0 -CAT-TCT-GTC-TCT-GAT-TGG-TTG-AGT-3 0 ); the annealing temperature was 61.58C. Positive results were confirmed using a PCR assay specific for MVM [34] . The primers used to amplify a 735-bp region from the Vp2 gene were MVM-2929 forward (5 0 -AAA-TTA-CTG-CAC-TAG-CAA-CTA-GAC-3 0 ) and MVM-3713 reverse (5 0 -CTT-CAG-GAA-AGG-TTG-ACA-GCA-3 0 ); the annealing temperature was 608C.
A 1056-bp product of genomic DNA (promoter region of Cd14) was amplified to confirm accurate DNA extraction from gametes. Primer sequences were 101 (5 0 -ATT-TGA-ACG-GTG-GGA-AAT-TG-3 0 ) and 102 (5 0 -CAG-AAG-CAA-CAG-CAA-CAA-GC-3 0 ); the annealing temperature was 558C. Real-time PCR was performed in a DNA Engine Opticon Real-Time PCR Detection System (Bio-Rad Laboratories, München, Germany) using the QuantiFast SYBR Green PCR Kit (Qiagen GmbH) and the parvovirus-specific primers NS1 forward (5 0 -AAG-CCA-TAG-CAC-AGG-CAG-TT-3 0 ) and NS1 reverse (5 0 -TGT-TTG-CTG-CCT-TTT-CCT-TT-3 0 ), amplifying a 196-bp product from the NS1 region. The annealing temperature was 608C. The threshold line was set in the linear region of the amplification curve above the baseline noise, and threshold cycle values were determined as the cycle number at which the threshold line crossed the amplification curve. After amplification, the specificity of the PCR was verified by both melt-curve analysis and gel electrophoresis to confirm that only a single product of the correct size was present. Standard curves were created from 1:2 dilutions of pooled DNA samples from spleens (initial concentration, 50 ng/ll) that correlated well to a curve created from 10-fold dilutions of a virus suspension (initial titer, 1024 hemagglutination units and 10 4 TCID 50 per ml, respectively [data not shown]). All amplification products were loaded onto a 1.5% SeaKem agarose gel (Biozym, Hamburg, Germany) containing SYBR Green (Gel Star, 4 ll/100ml; Biozym, Hessisch Oldendorf, Germany) and were visualized by UV light. Molecular weight markers were used to confirm the sizes of amplicons.
RESULTS
Detection of Viral DNA in Reproductive Organs
Reproductive organs, including ovary, oviduct, uterus, testis, epididymis, accessory glands (seminal vesicles and coagulation gland), and penis, were harvested every second (Table 1 ). All further experiments were scheduled according to the results of this first experiment, with Days 9-13 postinoculation being the optimal time for harvesting oocytes, sperm cells, and two-cell embryos.
Real-time PCR was used to compare relative amounts of viral DNA in reproductive organs with those in spleens and lymph nodes on Day 9 postinoculation (Fig. 1) . In female organs, especially in ovaries, the amount of viral DNA was comparable to that detected in spleens and mesenteric lymph nodes. In contrast, viral DNA was found to a lesser extent in male reproductive organs.
Detection of MVMi DNA in Oocytes
Oocytes were harvested on Day 12 postinoculation and were pooled into five groups consisting of 100 oocytes each. These were submitted either to 5-fold washing or 10-fold washing. The PCR detected viral DNA in one group of oocytes submitted to 5-fold washing and in one group submitted to 10-fold washing (Table 2 ). Because small amounts of washing media are transferred with the oocytes and might lead to a secondary contamination, we tested media of each wash step as well. Almost all washing media of the first three wash steps, as well as one medium of the fifth step and one medium of the seventh step, tested positive by PCR; notably, final washing media of the oocytes that tested positive after washing were negative, indicating that MVMi adhered to the oocytes during all wash steps.
Detection of MVMi DNA in Sperm Cells
Sperm cells were harvested on Day 11 postinoculation. Each sample was treated individually and submitted to either one, three, or five wash steps (Table 3) . After each of these wash steps, two samples tested positive by PCR (in total, six of 16 samples). However, the final washing medium tested positive in three samples as well. As observed after washing oocytes, viral DNA was detected in a major proportion of media of the first wash steps. 
Detection of MVMi DNA in Two-Cell Embryos
Two experimental settings were created to determine the risk of transmitting virus through infected females or males. In the first setting, female mice were infected and mated with uninfected males at Day 11 postinoculation (embryos were obtained at Day 13 postinoculation); in the second setting, males were infected and mated with uninfected females at Day 9 postinoculation (embryos were harvested 2 days later). As for oocytes, two-cell embryos were pooled into groups consisting of 100 cells each. All groups were submitted to 10-fold washing. Although washing media up to wash step six tested positive, MVMi DNA was not detected by PCR in two-cell embryos of either group (Table 4) . Notably, washing media tested positive only when female mice were infected and not when male mice were infected.
In Vitro Contamination of Oocytes
To determine to what extent MVMi is able to adhere to the zp, three groups of oocytes were contaminated in vitro and washed 10 times, and in half of the oocytes of each group, the zp was dissolved by Tyrode solution. Washing media tested positive up to wash step six. Oocytes submitted to PCR directly after 10-fold washing tested positive for viral DNA. Tyrode solution containing the dissolved zp tested positive for viral DNA by PCR, confirming that the virus firmly adheres to the zp even after 10 wash steps. Oocytes without zp tested positive as well; however, viral particles might have traversed into the cytoplasm during the dissolution of the zp. These findings are shown in Figure 2 .
DISCUSSION
Embryo transfer has become one of the primary mechanisms to eradicate infectious diseases from endemically infected mouse colonies. The objectives of this study were to assess risk of MVM transmission during rederivation and to provide use-oriented data that allow recommendation of measures to prevent transmission of MVM into barriermaintained mouse colonies. The possibility of parvoviral transmission during ET has been addressed recently because parvoviruses are associated with several risk aggravating attributes, including small size, affinity for mitotically active tissue, and enhanced environmental stability. However, data from experimental in vivo approaches delineating the critical factors that are associated with MVM-infected mice and their rederivation are missing so far.
For the related MPV, successful ET rederivation of CB17/ Icr-Prkdc scid mice experimentally infected with MPV1 has recently been shown, although antibody response (but no productive infection) was detected in recipients and progeny after ET with embryos derived from infected females [25] . This was not observed after ET when MPV-positive male mice were mated to MPV-negative embryo donors. In endemically infected mice, Agca et al. [24] detected MPV1 in ovarian tissue, sperm cells, embryos, and oocytes by PCR, corroborating the transmission of viral particles.
Similar in vivo-ex vivo data were not available for MVM. However, two recent in vitro studies by Mahabir et al. [22, 26] demonstrated that MVMp can be transmitted to recipients by in vitro-contaminated embryos even after washing 10 times before ET. In contrast, recipients of embryos arising from IVF with oocytes and MVM-exposed spermatozoa remained seronegative and were virus free, as well as their offspring. These findings might indicate that the risk of viral transmission is more substantial through the female side. However, this was not investigated experimentally using an in vivo approach. It remains unknown if and for how long adequate amounts of virus are present in the reproductive tract of female (and male) mice and whether MVMi is shed with gametes and embryos in immunocompetent mice. This is relevant because MVMp is localized to connective tissue elements of the intestine, to cells in mesenteric lymph nodes, and rarely to cells in other organs. MVMi primarily targets endothelium, lymphoid cells, and hematopoietic cells [35] .
Therefore, it was an unexpected finding of the in vivo approach used in this study that the amount of viral DNA detected in female reproductive organs on Day 9 postinoculation, especially ovaries, was comparable to the amount detected in spleens and mesenteric lymph nodes. A minority of reproductive organs already tested positive at Day 5 postinoculation and up to Day 30 postinoculation, demonstrating a risk for at least a 4-wk period. However, the highest incidence of positive organs was found on Day 9 and Day 13 postinoculation, with the percentage of PCR-positive organs declining rapidly after Day 15 postinoculation. We even found oocytes and sperm cells to be positive for MVMi DNA, but not two-cell We detected viral DNA to a lesser extent in male than in female reproductive organs by real-time PCR. Furthermore, washing media tested positive to a higher extent when two-cell embryos were derived from infected female mice compared with embryos derived from uninfected females mated to infected males. This may underline the notion that virus is more likely transmitted through the female side [22, 26] . However, six of 16 sperm samples of infected males tested positive after washing by PCR. This controversial observation between testing spermatozoa ex vivo and embryos after mating to infected males might be due to the method of preparing sperm cells by disintegrating the epididymis, which might lead to contamination of spermatozoa. This should be taken into account when sperm are shipped for assisted reproductive technologies.
Because we detected MVMi in oocytes despite extensive washing, we performed in vitro contamination studies of oocytes with MVMi. We found oocytes to be positive for viral DNA by PCR even after 10-fold washing with a dilution factor of approximately 1:100 per wash step, demonstrating that viral particles were not eliminated during this procedure. Furthermore, Tyrode solution containing the dissolved zp tested positive, verifying that the virus adhered firmly to the zp; this is underlined by the finding that media of the last wash steps tested negative. Therefore, our findings strongly indicate that even extensive washing before ET might not eliminate the virus completely from embryos. Together with previous findings showing that fluorescently (20 nm) labeled microspheres (similar in size to parvoviruses) penetrated into or crossed through the zp [22] , these data demonstrate that MVMi is capable of adhering firmly to embryos and might even cross the zp, as has been shown for several other small viruses such as Mengo virus, Coxsackie-B4, and even other autonomous parvoviruses [19] [20] [21] .
Overall our findings indicate that careful washing is essential for successful rederivation but might not completely remove parvovirus from oocytes, embryos, and spermatozoa. Further decontamination techniques might reduce the risk additionally; however, it has been demonstrated for Sendai virus that trypsin treatment did not eliminate all viral particles [36] . Centrifugation (e.g., using Percoll or Ficoll gradients) has been used to isolate spermatozoa free of infectious agents but was not successful after MPV infection [24] . We have seen that even 5-fold washing did not completely eliminate MVMi DNA from sperm cells.
Based on our results and recent data, we propose the following three recommendations for ET rederivation of mice (potentially) infected with parvovirus: (1) Compulsive testing is essential when performing rederivation. Because seroconversion to parvoviruses depends on several factors, including mouse strain, testing after rederivation should not rely exclusively on serological methods [37, 38] . Instead, spleens (and/or mesenteric lymph nodes) of donors, dams, and, if possible, surplus progeny should be evaluated by PCR. Testing of washing media by PCR is advisable, as demonstrated in this study. The testing of dams should take place directly after weaning because antibody response should have occurred by then, and the amount of MVMi DNA decreases with time, as shown in this study. If possible, surplus progeny should be tested by PCR as early as possible, at the latest after weaning for the reasons already stated. Furthermore, fecal samples can be investigated to detect viral shedding. Compulsive testing applies especially to rederivation of immunocompromised mouse strains. (2) Special care has to be taken regarding sufficient washing of gametes and embryos; therefore, at least 10 wash steps should be performed before ET. A sufficient dilution factor must be achieved (in this study, approximately 1:100 per wash step); therefore, washing should not be carried out in 4-well dishes (corresponding to a dilution factor of approximately 1:10 per wash step). However, washing might not completely remove parvovirus from oocytes and embryos. The use of decontamination techniques might be advisable when dealing with parvoviral infection. (3) The use of two-cell embryos is recommended for ET because viral DNA was not detected in two-cell embryos derived from in vivo-infected mice. Our data indicate that the risk of virus transmission may be substantially higher when performing IVF with gametes from infected animals. When IVF is performed, gametes should be derived after at least a 4-wk quarantine of the donor because we demonstrated that a minority of reproductive organs tested positive up to Day 30 postinoculation. Concerning the extensive exchange of genetically modified mice in recent years, special regard should be given to the fact that the shipment of gametes, which has been proposed as an alternative to sending live mice, may be a potential source for the introduction of disease into animal facilities.
In conclusion, a systematic assessment of the risk of MVM transmission during rederivation enabled us to recommend definite measures to prevent transmission of MVM. Based on our recommendations, ET can be an adequate method for rederivation of mouse strains with a manageable risk of transferring parvoviruses if certain precautions such as careful washing and accompanying testing are taken, while the exchange of gametes should be considered a risk factor.
